News & Updates

UNR844, an investigational topical lipoic acid choline ester eye drop, is safe and well-tolerated for the treatment of presbyopia and yields improvements in distance-corrected near visual acuity, a recent study has found.

Visual and anatomic responses to a previous dexamethasone (DEX) implant predicts patient response after switching to fluocinolone acetonide (FAc) implant, a recent study has found.

Blephasteam and TheraPearl, two warm compress medical devices worn over the eyes, achieve comparable efficacy in treating mild to moderate meibomian gland dysfunction (MGD), according to a recent study.

Infants with hyperglycaemia are at an increased risk of having retinopathy of prematurity (ROP), a recent study has found. Meanwhile, no such effect was observed for serum levels of glycated albumin (GlyA).

Patients with refractory uveitic macular edema are more likely to achieve complete response with tocilizumab than with antitumour necrosis factor alpha (anti-TNF-α) drugs, as reported in a study.

Cataract surgery is safe and does not confer an increased risk of developing late age-related macular degeneration over 10 years of follow-up, according to a study.

Children with retinopathy of prematurity (ROP) who receive antivascular endothelial growth factor (anti-VEGF) therapy fare better than their counterparts who undergo primary laser treatment, a study has found.

The varenicline-containing nasal spray OC-01 appears beneficial in the treatment of dry eye disease, producing improvements in natural tear film production and patient-reported symptoms with a tolerable safety profile, as shown in the phase III trial ONSET-2.

Unprecedented quarantine and social distancing measures implemented during the coronavirus disease 2019 (COVID-19) pandemic have resulted in a “myopia boom” in school-aged children in Hong Kong, according to results of a population-based study by the Chinese University of Hong Kong (CUHK).